# SLC25A15

## Overview
The SLC25A15 gene encodes the mitochondrial ornithine transporter 1 (ORC1), a member of the solute carrier family 25, which is integral to mitochondrial function. This transmembrane protein is primarily involved in the urea cycle, facilitating the exchange of cytosolic ornithine with intramitochondrial citrulline and protons (H+), a process crucial for nitrogen disposal in the liver (Palmieri2014Mitochondrial; Palmieri2013The). Structurally, ORC1 is characterized by six transmembrane alpha-helices that form a barrel-like structure, enabling its transport function (Palmieri2013The; Palmieri2004The). Mutations in SLC25A15 can lead to hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome, underscoring its clinical significance (Palmieri2020Diseases; Martinelli2015The). The gene's role in metabolic processes and its potential interactions with other mitochondrial proteins highlight its importance in maintaining cellular homeostasis (Caldovic2022Assessing).

## Structure
The SLC25A15 gene encodes the mitochondrial ornithine carrier 1 (ORC1), a member of the solute carrier family 25. This protein is characterized by a tripartite structure with three tandemly repeated homologous domains, each approximately 100 amino acids long, and contains six transmembrane alpha-helices (Palmieri2013The; Palmieri2004The). These helices form a barrel-like structure surrounding a central cavity, which is open towards the cytosol, facilitating the transport of ornithine in exchange for citrulline and H+ ions (Palmieri2014Mitochondrial; Tessa2009Identification).

The protein's structure includes a signature sequence motif, PX[D/E]XX[K/R]X[K/R], which is common among mitochondrial carriers and plays a crucial role in substrate binding and transport (Palmieri2013The). The ORC1 protein's function is further supported by a network of salt bridges formed by charged residues, which act as a gate within the carrier cavity (Palmieri2014Mitochondrial).

Mutations in the SLC25A15 gene can disrupt these structural features, leading to reduced transport activity and contributing to the pathogenesis of hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome (Tessa2009Identification).

## Function
The SLC25A15 gene encodes the mitochondrial ornithine transporter 1 (ORC1), which plays a crucial role in the urea cycle by facilitating the exchange of cytosolic ornithine with intramitochondrial citrulline and a proton (H+). This exchange is essential for linking the urea synthesis reactions occurring in the cytosol to those in the mitochondria, particularly in the liver, where it is vital for the proper disposal of excess nitrogen through the urea cycle, preventing the accumulation of toxic levels of ammonia in the body (Palmieri2014Mitochondrial; Palmieri2013The).

ORC1 is expressed at higher levels than its isoform ORC2 in tissues, and ORC2 cannot fully replace ORC1's function due to its lower affinity for ornithine and citrulline. In addition to its role in the urea cycle, ORC1 facilitates the import of lysine, arginine, and histidine into mitochondria, which is necessary for protein synthesis and arginine degradation (Palmieri2004The). The ornithine formed by arginine hydrolysis can be removed by ornithine aminotransferase in the mitochondrial matrix, a process regulated by dietary protein content (Palmieri2004The). The proper function of ORC1 is critical to prevent the accumulation of ammonia and other toxic metabolites, which can lead to metabolic disorders (Palmieri2014Mitochondrial).

## Clinical Significance
Mutations in the SLC25A15 gene, which encodes the mitochondrial ornithine carrier ORC1, are responsible for hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome, a rare autosomal recessive disorder. This condition is characterized by elevated levels of ornithine and ammonia in the blood, along with urinary excretion of homocitrulline. Clinically, HHH syndrome presents with a wide range of symptoms, including acute episodes of vomiting, confusion, and coma, as well as chronic issues such as developmental delay, intellectual disability, and seizures (Palmieri2013The; Martinelli2015The).

The SLC25A15 gene is located on chromosome 13q14.11 and consists of 7 exons. Mutations in this gene can include missense, small insertions, deletions, nonsense mutations, and rearrangements. These mutations often result in non-conservative substitutions that alter the protein's structure and function, affecting substrate binding and translocation (Martinelli2015The). Two common mutations, p.F188del and p.R179*, are prevalent in specific populations due to founder effects and account for a significant portion of cases (Palmieri2020Diseases; Martinelli2015The).

Management of HHH syndrome involves controlling hyperammonemia with a protein-restricted diet and supplements like citrulline or arginine. The prognosis varies, with some patients experiencing severe symptoms while others lead nearly normal lives (Martinelli2015The).

## Interactions
The SLC25A15 gene encodes the mitochondrial ornithine transporter 1 (ORC1), which is involved in the urea cycle by facilitating the exchange of cytosolic ornithine and intramitochondrial citrulline. While specific protein interactions involving SLC25A15 are not extensively detailed, it is suggested that the protein may form transient interactions with other mitochondrial transporters and enzymes involved in the urea cycle. These interactions could potentially regulate metabolic processes by forming clusters rather than stable multi-enzyme complexes (Caldovic2022Assessing).

The clustering of mitochondrial urea cycle enzymes, including those encoded by SLC25A15, presents challenges in studying their protein-protein interactions. Traditional methods often yield inconclusive results when applied to these clustered proteins, suggesting that the interactions may not be as strong or specific as expected for stable complexes. This indicates that the conditions used in vitro may not accurately mimic the in vivo environment, or that the interactions are inherently weak (Caldovic2022Assessing).

Despite the lack of detailed interaction data, the role of SLC25A15 in the urea cycle and its potential interactions with other proteins highlight its importance in metabolic processes and its involvement in conditions such as hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome (Palmieri2014Mitochondrial; Palmieri2004The).


## References


[1. (Tessa2009Identification) Alessandra Tessa, Giuseppe Fiermonte, Carlo Dionisi-Vici, Eleonora Paradies, Matthias R. Baumgartner, Yin-Hsiu Chien, Carmela Loguercio, Helene Ogier de Baulny, Marie-Cecile Nassogne, Manuel Schiff, Federica Deodato, Giancarlo Parenti, S. Lane Rutledge, M. Antonia Vilaseca, Mariarosa A.B. Melone, Gioacchino Scarano, Luiz Aldamiz-Echevarría, Guy Besley, John Walter, Eugenia Martinez-Hernandez, Jose M. Hernandez, Ciro L. Pierri, Ferdinando Palmieri, and Filippo M. Santorelli. Identification of novel mutations in theslc25a15gene in hyperornithinemia-hyperammonemia-homocitrullinuria (hhh) syndrome: a clinical, molecular, and functional study. Human Mutation, 30(5):741–748, February 2009. URL: http://dx.doi.org/10.1002/humu.20930, doi:10.1002/humu.20930. This article has 78 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.20930)

[2. (Martinelli2015The) Diego Martinelli, Daria Diodato, Emanuela Ponzi, Magnus Monné, Sara Boenzi, Enrico Bertini, Giuseppe Fiermonte, and Carlo Dionisi-Vici. The hyperornithinemia–hyperammonemia-homocitrullinuria syndrome. Orphanet Journal of Rare Diseases, March 2015. URL: http://dx.doi.org/10.1186/s13023-015-0242-9, doi:10.1186/s13023-015-0242-9. This article has 66 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13023-015-0242-9)

[3. (Palmieri2020Diseases) Ferdinando Palmieri, Pasquale Scarcia, and Magnus Monné. Diseases caused by mutations in mitochondrial carrier genes slc25: a review. Biomolecules, 10(4):655, April 2020. URL: http://dx.doi.org/10.3390/biom10040655, doi:10.3390/biom10040655. This article has 75 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biom10040655)

[4. (Palmieri2014Mitochondrial) Ferdinando Palmieri. Mitochondrial transporters of the slc25 family and associated diseases: a review. Journal of Inherited Metabolic Disease, 37(4):565–575, May 2014. URL: http://dx.doi.org/10.1007/s10545-014-9708-5, doi:10.1007/s10545-014-9708-5. This article has 202 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10545-014-9708-5)

[5. (Palmieri2013The) Ferdinando Palmieri. The mitochondrial transporter family slc25: identification, properties and physiopathology. Molecular Aspects of Medicine, 34(2–3):465–484, April 2013. URL: http://dx.doi.org/10.1016/j.mam.2012.05.005, doi:10.1016/j.mam.2012.05.005. This article has 612 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.mam.2012.05.005)

[6. (Caldovic2022Assessing) Ljubica Caldovic, Shivaprasad Bhuvanendran, and Jyoti Jaiswal. Assessing Protein Interactions for Clustering of Mitochondrial Urea Cycle Enzymes, pages 73–92. Springer US, 2022. URL: http://dx.doi.org/10.1007/978-1-0716-2269-8_5, doi:10.1007/978-1-0716-2269-8_5. This article has 0 citations.](https://doi.org/10.1007/978-1-0716-2269-8_5)

[7. (Palmieri2004The) Ferdinando Palmieri. The mitochondrial transporter family (slc25): physiological and pathological implications. Pfl�gers Archiv European Journal of Physiology, 447(5):689–709, February 2004. URL: http://dx.doi.org/10.1007/s00424-003-1099-7, doi:10.1007/s00424-003-1099-7. This article has 624 citations.](https://doi.org/10.1007/s00424-003-1099-7)